Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Letouzé, Eric; Shinde, Jayendra; Renault, Victor; Couchy, Gabrielle; Blanc, Jean-Frédéric; Tubacher, Emmanuel; Bayard, Quentin; Bacq, Delphine; Meyer, Vincent; Semhoun, Jérémy; Bioulac-Sage, Paulette; Prévôt, Sophie; Azoulay, Daniel; Paradis, Valérie; Imbeaud, Sandrine; Deleuze, Jean-François; Zucman-Rossi, Jessica
• Is Part Of: Nature communications. Volume 8:Issue 1(2017)
• Page Start: 1
• Page End: 13
• Publication Date: 2017-12
• Subjects: Biology -- Periodicals; Physical sciences -- Periodicals; 505
• DOI: 10.1038/s41467-017-01358-x
• Languages: English
• ISSNs: 2041-1723

Abstract

Abstract Genomic alterations driving tumorigenesis result from the interaction of environmental exposures and endogenous cellular processes. With a diversity of risk factors, liver cancer is an ideal model to study these interactions. Here, we analyze the whole genomes of 44 new and 264 published liver cancers and we identify 10 mutational and 6 structural rearrangement signatures showing distinct relationships with environmental exposures, replication, transcription, and driver genes. The liver cancer-specific signature 16, associated with alcohol, displays a unique feature of transcription-coupled damage and is the main source ofCTNNB1 mutations. Flood of insertions/deletions (indels) are identified in very highly expressed hepato-specific genes, likely resulting from replication-transcription collisions. Reconstruction of sub-clonal architecture reveals mutational signature evolution during tumor development exemplified by the vanishing of aflatoxin B1 signature in African migrants. Finally, chromosome duplications occur late and may represent rate-limiting events in tumorigenesis. These findings shed new light on the natural history of liver cancers. Tumorigenesis is a complex process driven by numerous risk factors. Here, genomic analysis of liver cancer reveals the evolution of mutational signatures during tumor development, highlighting mutational and structural signatures linked to environmental exposures and endogenous cellular processes.